News

      December 6, 2021 News

      Award-Top Immunotherapy solution

      providers in Europe 2021

      Read more

      November 25, 2021 News

      Oblique Therapeutic’s interim report for

      January – September 2021 (Q3 2021) is available.

      Read more

      November 16, 2021 News

      Oblique Therapeutics welcomes Cecilia Larsson

      as IRM - Investor Relations Manager position at the Gothenburg Office

      Read more

      November 16, 2021 News

      Oblique Therapeutics welcomes Mats Lindskog

      as CBO - Chief Business Officer working out from Stockholm Office

      Read more

      October 6, 2021 News

      New Press Article in Svenska Dagbladet

      in the INNOVATIVA FÖRETAG edition - October 2021

      Read more

      October 5, 2021 News

      Nobel Prize 2021 in Physiology or Medicine

      for discoveries of receptors for temperature and touch.

      Read more

      October 4, 2021 News

      Oblique Therapeutics announces that it has reached a key milestone

      in its aKRAS antibody program and achieved validation of its Abiprot® platform.

      Read more

      September 15, 2021 News

      Oblique Therapeutics: one of the 101 Top

      Pharmaceutical Start Ups and Companies to follow in Sweden (2021).

      Read more

      September 1, 2021 News

      Our Founder & CEO Prof. Owe Orwar has been named a winner

      in the CEO Today Healthcare Awards for 2021 by CEO Today Magazine.

      Read more

      June 18, 2021 News

      Annual General Meeting On Wednesday the 15th of June 2021,

      we held our Annual General Meeting to conclude our year and discuss about the future. Exciting time.

      Read more
      1 2 3